A team of scientists at Johns Hopkins Medical School has identified a drug that might genuinely help to mitigate the most severe effect of COVID-19: the cytokine storm. If it works, this drug could greatly reduce the need for ventilators and save many …
Mauro Ferrari resigned after three months in the job, apparently disillusioned with the bureaucracy of the European Commission and opposition to his COVID-19 battle plan.
Biopharma Venture Capital funding hit all-time-highs during the first quarter of 2020. Author shares the data and reflects on the market in light of COVID.
Systemic changes affect how medical care is provided in the future. Some businesses are ready to meet the challenge.
As President Trump said he would withhold U.S. payments to the WHO at a press conference yesterday before seemingly backtracking, what countries contribute the most financially to the organization?
Pandemics don’t occur in a vacuum, but in societies of people who have existing beliefs and alliances.
To reopen our economy and keep it open, we need to make testing for COVID-19 our top priority. We are still not performing enough tests. The barriers to more widespread testing are not insurmountable but need focus and priority by the federal government.
Last June more than 20 million Indonesians went back to their home villages to spend time with family during a vast internal migration called Mudik. This year’s edition is in late May – and public health experts warn it could be a “bomb” of COVID-19 ca…
Researchers are turning to other viruses as allies in the race to develop a vaccine against the coronavirus that causes COVID-19.
For the sake of science, you might be denied a drug. Fair?
